For investors looking for momentum, Invesco BulletShares 2027 Corporate Bond ETF (BSCR - Free Report) is probably a suitable pick. The fund just hit a 52-week high and is up 22.8% from its 52-week low price of $17.89/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
BSCR in Focus
This ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Nasdaq Bulletshares USD Corporate Bond 2027 Index. It has an AUM of $209.3 million and charges 10 basis points (bps) in annual fees.
Why the Move?
The Federal Reserve has announced new initiatives to support the ailing U.S. economy. The central bank has pledged to make individual corporate bonds purchases under its Secondary Market Corporate Credit Facility (SMCCF). Notably, under the SMCCF emergency lending program that has a capacity of $250 billion, the Fed has already invested about $5.5 billion in ETFs that buy corporate bonds. The Fed has pledged to keep pumping in stimulus to support the economy and strengthen it. These factors are making funds like BSCR attractive investment options. Also, the coronavirus outbreak raising global economic slowdown concerns might spur its demand among investors.
More Gains Ahead?
It seems like the fund will remain strong, with a positive weighted alpha of 7.90, which gives cues of further rally.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors looking for momentum, Invesco BulletShares 2027 Corporate Bond ETF (BSCR - Free Report) is probably a suitable pick. The fund just hit a 52-week high and is up 22.8% from its 52-week low price of $17.89/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
BSCR in Focus
This ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Nasdaq Bulletshares USD Corporate Bond 2027 Index. It has an AUM of $209.3 million and charges 10 basis points (bps) in annual fees.
Why the Move?
The Federal Reserve has announced new initiatives to support the ailing U.S. economy. The central bank has pledged to make individual corporate bonds purchases under its Secondary Market Corporate Credit Facility (SMCCF). Notably, under the SMCCF emergency lending program that has a capacity of $250 billion, the Fed has already invested about $5.5 billion in ETFs that buy corporate bonds. The Fed has pledged to keep pumping in stimulus to support the economy and strengthen it. These factors are making funds like BSCR attractive investment options. Also, the coronavirus outbreak raising global economic slowdown concerns might spur its demand among investors.
More Gains Ahead?
It seems like the fund will remain strong, with a positive weighted alpha of 7.90, which gives cues of further rally.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BSCR - FREE